John A. Scarlett - 06 Jun 2024 Form 4 Insider Report for GERON CORP (GERN)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GERN	Employee Stock Option (right to buy)	Award	$0	+1,000,000		$0.000000	1,000,000	06 Jun 2024	Common Stock	1,000,000	$1.72	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Performance-based stock option granted on November 7, 2018 and vested in full on June 6, 2024 upon approval by the US FDA for imetelstat in lower risk MDS.